Icomb 2,5 Mg/2,5 Mg

Ramipril and Amlodipine besilate, the active ingredients in Icomb 2,5 Mg/2,5 Mg, are an ACE inhibitor and a calcium channel blocker presented as a 2.5 mg/2.5 mg oral tablet for oral use. They treat hypertension in adult patients.

GNH USA supplies Icomb 2,5 Mg/2,5 Mg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Icomb 2,5 Mg/2,5 Mg combines ramipril and amlodipine to manage hypertension, a condition of elevated arterial pressure. - Essential hypertension: reduces systolic and diastolic blood pressure, decreasing cardiovascular risk. - Secondary hypertension: assists in blood pressure control when underlying causes are present. - High blood pressure: provides sustained antihypertensive effect for long‑term management.

Icomb 2,5 Mg/2,5 Mg may be associated with several adverse reactions, which are categorized by frequency.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness: especially after first doses. - Peripheral edema: swelling of ankles or feet. - Headache: mild to moderate intensity. - Flushing: transient warmth and redness. - Fatigue: general tiredness.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Severe hypotension: marked drop in blood pressure causing fainting. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Myocardial infarction: rare but reported cardiac events.

Before prescribing Icomb 2,5 Mg/2,5 Mg, clinicians should consider several precautionary measures. - Blood pressure monitoring: ensure adequate control and avoid excessive hypotension. - Renal function: assess creatinine clearance in patients with renal impairment. - Hepatic disease: use cautiously in moderate to severe liver dysfunction. - Pregnancy: avoid use during pregnancy due to fetal risk. - Electrolytes: monitor potassium levels when combined with potassium‑sparing agents. - Store below 25°C: keep in original container, protect from moisture and light.

Icomb 2,5 Mg/2,5 Mg can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - ACE inhibitor with aliskiren: increased risk of renal impairment and hyperkalemia. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - NSAIDs (e.g., ibuprofen, naproxen): can blunt antihypertensive effect and worsen renal function. - Other ACE inhibitors or ARBs: additive risk of hypotension and angioedema. - Lithium: may increase lithium levels leading to toxicity.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., clarithromycin, ketoconazole): may raise amlodipine concentrations. - Diuretics (e.g., thiazides): can enhance hypotensive effect. - Other antihypertensives (e.g., beta‑blockers): may require dose adjustment. - Grapefruit juice: may increase amlodipine exposure. - Antidiabetic agents: blood glucose may improve, risking hypoglycemia.